相关实验视频
Updated: Jun 6, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
用一块石头杀死两只鸟:肝病学家对代谢功能障碍相关的脂肪性肝病和心力衰竭的方法
Yusuke Hirao1, Clarke Morihara1, Tomoki Sempokuya2
1Department of Medicine, John A Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI 96813, United States.
与代谢功能障碍相关的脂肪性肝病 (MASLD) 是心力衰竭 (HF) 的危险因素. 针对HF的指导药物在治疗MASLD方面表现有前途,但需要更多的研究.
科学领域:
- 心脏病学 心脏病学
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 心力衰竭 (HF) 是一个重大的全球健康挑战.
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 是HF的新兴风险因素,具有相似的潜在病理生理学.
- 了解MASLD和HF之间的联系对于开发有效的治疗方法至关重要.
研究的目的:
- 评估HF和MASLD的共同病理生理学.
- 评估目前用于管理这两种疾病的治疗策略.
- 审查指南导向医疗疗 (GDMT) 对MASLD的影响.
主要方法:
- 关于Arriola-Montenegro等人最近发表的一篇文章的文献评论.
- 汇总了HF和MASLD之间共享的病理生理机制.
- 评估现有的治疗选择和临床试验数据.
主要成果:
- 包括ACEI,ARB,MRA和SGLT-2i在内的HF的指南导向医疗疗 (GDMT) 已证明对MASLD有有益影响.
- 这些药物在HF治疗中具有基础性,具有双重治疗作用的潜力.
- 需要进一步的研究来证实疗效和探索新疗法.
结论:
- 在HF和MASLD之间共享的病理生理学表明潜在的重叠治疗益处.
- 目前用于HF的GDMT,特别是ACEI,ARB,MRA和SGLT-2i,显示出对MASLD管理的希望.
- 强有力的临床研究是必要的,以验证新疗法,并确认现有治疗方法的疗效对于这两个条件.
更多相关视频
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
08:35A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
相关概念视频
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Pathophysiology of Heart Failure
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Chronic Pancreatitis II: Collaborative Care
Assessment: